Status:
UNKNOWN
Safety and Efficacy Study of the Z-Lig Medical Device Compared to Allograft
Lead Sponsor:
Aperion Biologics, Inc.
Conditions:
Ruptured Anterior Cruciate Ligaments
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of this Trial is to demonstrate the safety and efficacy of the Investigational Device for the treatment of ruptured Anterior Cruciate Ligament (ACL) of the knee compared to Allograft.
Detailed Description
Current techniques to reconstruct ruptured ACLs utilize either autologous tissue or allograft (cadaver) tissue. Both treatments have well-documented shortcomings (i.e., autologous tissue exposes patie...
Eligibility Criteria
Inclusion
- Contact Sponsor
Exclusion
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01245400
Start Date
November 1 2010
End Date
April 1 2017
Last Update
March 13 2014
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Sponsor, Belgium
2
Contact Sponsor, Denmark
3
Bologna, Italy
4
Contact Sponsor, Netherlands